rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
1999-1-28
|
pubmed:abstractText |
The aim of the present study was to determine the acute effects of the "Ecstasy" analogue MDE (3, 4-methylendioxyethamphetamine) on the cerebral glucose metabolism (rMRGlu) of healthy volunteers.
|
pubmed:language |
ger
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0029-5566
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
262-7
|
pubmed:dateRevised |
2007-1-12
|
pubmed:meshHeading |
pubmed-meshheading:9868707-Administration, Oral,
pubmed-meshheading:9868707-Adult,
pubmed-meshheading:9868707-Brain,
pubmed-meshheading:9868707-Brain Mapping,
pubmed-meshheading:9868707-Double-Blind Method,
pubmed-meshheading:9868707-Female,
pubmed-meshheading:9868707-Fluorodeoxyglucose F18,
pubmed-meshheading:9868707-Glucose,
pubmed-meshheading:9868707-Hallucinogens,
pubmed-meshheading:9868707-Humans,
pubmed-meshheading:9868707-Magnetic Resonance Imaging,
pubmed-meshheading:9868707-Male,
pubmed-meshheading:9868707-Middle Aged,
pubmed-meshheading:9868707-N-Methyl-3,4-methylenedioxyamphetamine,
pubmed-meshheading:9868707-Radiopharmaceuticals,
pubmed-meshheading:9868707-Tomography, Emission-Computed
|
pubmed:year |
1998
|
pubmed:articleTitle |
[Investigations on the effect of "ecstasy" on cerebral glucose metabolism: an 18-FDG PET study].
|
pubmed:affiliation |
Kliniken für Nuklearmedizin, Universitätsklinikum der RWTH Aachen, Deutschland.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Randomized Controlled Trial
|